Beyond the antibodies: serum metabolomic profiling of myasthenia gravis

ConclusionIn patients presenting to the clinic with seropositive MG, metabolomic profiling is capable of distinguishing patients with disease from those without. These results provide an important first step towards a potential biomarker for improving MG identification.
Source: Metabolomics - Category: Biology Source Type: research